RE: RE: RE: why is sp so low Good point Scott.
The number of shares outstanding is one thing, however the market cap is something else.
The credibility issue have been discussed in the past, and only deliveries will take care of it. But it doesn't explain everything.
The market cap is at $ 47M, and we have in place the only technology that can replace the Cohn ethanol precipitation in place since 70 years. Apart the Albumin, the recovery level of the PPPS is far superior than the Cohn. The PPPS can also recover what Cohn can't. And looking at a few things, I think I can assume the purity of albumin recovered by PLI seems to be superior.
This alone worth more than the current market cap. Is the problem is that this company is not well understood?
PLI is a biotech, and a supplier for pharma and biotech. PLI can't go faster than their clients. However, the technology so far has delivered.
So, why analysts and investors are willing to give value to other biotech with mainly one or a few molecules in devellopment that are strictly burning cash, base on a theorical future event, but can't do the same with PLI, which have showned progress and business development over the last years?
I know that a lot of people will talked about the past over promises/under delivery situation. But at one point, isn't the time to stop driving only looking in the retrovisor, and look ahead?
The asian market is believing, and WIBP have proven it, and Taîwan Have followed, based on what they see in Wuhan. So like Scott pointed out, other deals are likely to come forward from Asia.
The cash issue still a problem, but frankly, can anyone believe that PLI could go in bankruptcy?
Will Octapharma will let go down Octaplas LG if PLI only need a few millions? WIBP have invested over $ 100M, the "UNKNOW" global pharma has also spent hundreds of millions on a product that also depend on PLI technology. The worst case scenario would be a loan from one of it's major clients. But like any other business, borrowing money from your clients is not the first option.
Stockbuphoon, I know you have an issue with Pierre's wage. However, I think he also puts his balls on the table to back up the company, and frankly, I'm not sure that the company would be existing now, if he wasn't there. Even in the worst stormy period, he never quit the ship and keep his hands on the wheel. He can easily make the same salary elsewhere without working 7 days a week and spend his time in airports. People should give him also the credit he deserved.
I'm again optimist, but there are signs that PLI have already turned the corner, and when there will be a full value given to the potential, the market cap will easily go over $ 100M.
You don't trust the management? Fine, but trust the big pharma that signed deals based on PLI technology and investors and that have invested a lot of money in PLI. They just can't be all dumb!!!
My opinion only.